150 related articles for article (PubMed ID: 12198335)
1. Chronopharmacology of cardiovascular therapy.
White WB; LaRocca GM
Blood Press Monit; 2002 Aug; 7(4):199-207. PubMed ID: 12198335
[No Abstract] [Full Text] [Related]
2. [Drug correction of myocardial ischemia in patients with chronic obstructive bronchitis].
Chicherina EN; Malykh SV
Probl Tuberk Bolezn Legk; 2003; (11):19-22. PubMed ID: 14689792
[TBL] [Abstract][Full Text] [Related]
3. Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.
Glasser SP; Frishman W; White WB; Stone P; Johnson MF
Clin Cardiol; 2000 Jul; 23(7):524-9. PubMed ID: 10894441
[TBL] [Abstract][Full Text] [Related]
4. [Calcium antagonist therapy of middle-aged and aged patients with angina pectoris during the outpatient stage of rehabilitation].
Pimenov LT; Ezhov AV; Churshin AD
Klin Med (Mosk); 1995; 73(5):69-71. PubMed ID: 8815289
[No Abstract] [Full Text] [Related]
5. Clinical chronopharmacology of the cardiovascular system: hypertension and coronary heart disease.
Lemmer B
Clin Ter; 2006; 157(1):41-52. PubMed ID: 16669551
[TBL] [Abstract][Full Text] [Related]
6. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
[TBL] [Abstract][Full Text] [Related]
7. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
[No Abstract] [Full Text] [Related]
8. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
De Rosa ML; Giordano A; Melfi M; Della Guardia D; Ciaburri F; Rengo F
Int J Cardiol; 1998 Jan; 63(1):27-35. PubMed ID: 9482142
[TBL] [Abstract][Full Text] [Related]
9. Case studies in hypertension. Dihydropyridine/nondihydropyridine calcium channel blocker combination therapy.
Handler J
J Clin Hypertens (Greenwich); 2005 Jan; 7(1):50-3. PubMed ID: 15655389
[No Abstract] [Full Text] [Related]
10. Impact of circadian amplitude and chronotherapy: relevance to prevention and treatment of stroke.
Shinagawa M; Kubo Y; Otsuka K; Ohkawa S; Cornélissen G; Halberg F
Biomed Pharmacother; 2001; 55 Suppl 1():125s-132s. PubMed ID: 11774859
[TBL] [Abstract][Full Text] [Related]
11. A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning.
Smith DH; Neutel JM; Weber MA
Am J Hypertens; 2001 Jan; 14(1):14-9. PubMed ID: 11206672
[TBL] [Abstract][Full Text] [Related]
12. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
Hermida RC
Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
[TBL] [Abstract][Full Text] [Related]
13. Effects of diltiazem retard on ambulatory blood pressure and heart rate variability in patients with essential hypertension.
Kawano Y; Makino Y; Okuda N; Takishita S; Omae T
Blood Press Monit; 2000 Jun; 5(3):181-5. PubMed ID: 10915232
[TBL] [Abstract][Full Text] [Related]
14. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group.
Deedwania PC; Pool PE; Thadani U; Eff J
Am J Cardiol; 1997 Aug; 80(4):421-5. PubMed ID: 9285652
[TBL] [Abstract][Full Text] [Related]
15. Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease.
Smolensky MH; Portaluppi F
Am Heart J; 1999 Apr; 137(4 Pt 2):S14-S24. PubMed ID: 10097242
[TBL] [Abstract][Full Text] [Related]
16. Effects of diltiazem on left ventricular systolic and diastolic function in hypertrophic cardiomyopathy.
Betocchi S; Piscione F; Losi M A; Pace L; Boccalatte M; Perrone-Filardi P; Cappelli-Bigazzi ; Briguori C; Manganelli F; Ciampi Q; Salvatore M; Chiariello M
Am J Cardiol; 1996 Aug; 78(4):451-7. PubMed ID: 8752192
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
[TBL] [Abstract][Full Text] [Related]
18. Sustained-release diltiazem reduces myocardial ischemic episodes in end-stage renal disease: a double-blind, randomized, crossover, placebo-controlled trial.
Cice G; Di Benedetto A; D'Andrea A; D'Isa S; Ferrara L; Russo PE; Iacono A; Calabrò R
J Am Soc Nephrol; 2003 Apr; 14(4):1006-11. PubMed ID: 12660335
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
Hermida RC
Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
[TBL] [Abstract][Full Text] [Related]
20. The role of calcium channel blockers in the treatment of hypertension.
Halperin AK; Cubeddu LX
Am Heart J; 1986 Feb; 111(2):363-82. PubMed ID: 3511651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
